Advised a consortium comprised of QIC, Chinese investment fund Pagoda and Goldman Sachs’ private equity arm on various tax issues associated with its successful bid to acquire a majority stake in the Icon Cancer Care Group which operates a vertically integrated cancer care business in Australia and Singapore.